WALGREENS FISCAL TOPS 2Q forecasts such as the purchase of private capital awaits

WALGREENS FISCAL TOPS 2Q forecasts such as the purchase of private capital awaits

Walgreens delivered a second fiscal quarter better than expected and a loss less than the month after announcing that he would do so be bought by a private capital company.

The pharmacy chain reserved pharmacy sales profits, and its Villagemd clinic business in which it offered a smaller balance in the recently completed quarter.

In general, Walgreens said Tuesday that he lost $ 2.85 billion compared to a loss of $ 5.91 billion in the quarter of the previous year. The tight results that do not count the unique elements totaled 63 cents per action in the most recent quarter. Sales grew 4% to $ 38.59 billion

Analysts expected fiscal profits from the second quarter of 53 cents per share in approximately $ 38 billion in income, according to the FACTSET data firm.

Walgreens said in March that he had agreed to be acquired by the private capital firm Sycamore Partners in an agreement with a capital value of just under $ 10 billion.

The purchase occurred when the pharmacy chain deals with a series of problems that include thin prescription reimbursement, growing costs and a business of the Villagemd clinic that has struggled to gain traction with patients.

Deerfield’s company, Illinois is reducing costs and closing stores. In January, he said it was suspend a quarterly dividend It has been offered for more than 90 years.

In its second fiscal quarter, the sales of the established American pharmacies of Walgreens increased by 12%, they partially helped for more recipes. But retail sales in those stores fell around 3%.

Walgreens Boots Alliance Inc. It also has almost 3,700 international stores, with locations in the United Kingdom, Mexico, Thailand and Ireland. The American segment is most of its business.

See also  Dave Shapiro, an innovative music executive, dies in a San Diego air accident at 42

In the recent quarter, Walgreens said that his operational loss included a charge for deterioration of $ 3 billion that is not partly linked to his Villagemd business. That compares with a position of more than $ 12 billion in the quarter of the previous year.

Walgreens withdrew his annual forecast due to his pending agreement and did not organize a telephone conference with analysts to discuss the results.

The company’s shares advanced 19 cents at $ 10.90 on Tuesday morning, while market rates organized a larger demonstration of losses on Monday.

Leave a Reply

Your email address will not be published. Required fields are marked *

3 × 2 =

Top